Biomea Fusion Inc

BMEAStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$1.25

Today

-3.8%

YTD

+3.3%

About

Biomea Fusion, Inc. is a biopharmaceutical company dedicated to developing innovative therapeutics for patients with serious medical needs. Operating in the US, the mission of Biomea Fusion revolves around fighting diseases through scientific discovery. Biomea functions within the healthcare sector, particularly specialised in biopharmaceuticals. Its primary service is creating novel treatments with covalent small molecules. It operates independently, continually working on new therapies that could find a permanent place within the medical industry. Monitor the BMEA share price by adding it to your eToro watchlist.

Price chart

Closing price history for BMEA (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.61

P/S (TTM)0.00

P/B (TTM)7.76

Market cap$94.23M

Cap tierMicro-cap

Industry avg P/E-7.28

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-164.14%

ROA-59.14%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$0.50

Free cash flow$-47.06M

Total debt$877,000.00

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.65

Employees41

Next earnings3 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.